Two Sigma Securities’s Drugs Made In America Acquisition Corp Rights DMAAR Stock Holding History
Bought
Maintained
Sold
Other funds holding DMAAR
Two Sigma Securities's DMAAR Position: Q3 2026 in Review
Two Sigma Securities opened a new position in Drugs Made In America Acquisition Corp Rights (DMAAR) in Q3 2026: 17,393 shares worth $1.74K. The stake represents ﹤0.01% of the portfolio and ranks #1635 among its holdings.
32 funds tracked by Wall St. Rank hold DMAAR as of Q3 2026.
- Two Sigma Securities held 17,393 shares of Drugs Made In America Acquisition Corp Rights worth $1.74K as of Q3 2026.
- Drugs Made In America Acquisition Corp Rights was a new Two Sigma Securities position in Q3 2026.
- Drugs Made In America Acquisition Corp Rights made up ﹤0.01% of Two Sigma Securities's portfolio in Q3 2026, its #1635 holding.
- 32 funds tracked by Wall St. Rank held Drugs Made In America Acquisition Corp Rights as of Q3 2026.
Based on Two Sigma Securities's 13F filing for Q3 2026, filed 16 Nov 2026.